Drug discovery is challenging and involves several complexities. In order to continue to add new molecules their pipelines, drug developers are opting to outsource such operations to contract research organizations (CROs). Outsourcing of peptides and macrocycle drug discovery has emerged as one of the recent trends in the overall pharmaceutical domain.
Roots Analysis has announced the addition of “Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020-2030” report to its list of offerings.
The report features an extensive study on the current market landscape and future of companies offering services for peptide therapeutics and macrocycle drug discovery operations. The study includes in-depth analyses, highlighting the capabilities of various service / technology providers engaged in this market. Amongst other elements, the report includes:
Key Market Insights
§ More than 35 industry players claim to offer services for the identification, characterization and development of peptides and macrocycle-based pharmacological lead candidates
§ Several technology developers have made significant contributions in terms of developing novel platforms, based on a variety of innovative approaches, for the discovery of peptide-based drugs and macrocyclic molecules.
§ A detailed assessment of the current market landscape of companies offering peptide and macrocycle drug discovery services
§ An insightful geographical benchmarking of the capabilities of companies of various sizes, highlighting the key focus areas, comparing their existing strengths both within and beyond their respective peer groups (based on geography and company size).
An in-depth analysis of peptide platform and library service providers, featuring information on their company details, purpose of the platform, type of synthetic peptides manufactured and platform access model.
To order this 180+ page report, which features 90+ figures and 85+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/peptides-and-macrocycle-discovery/300.html
The USD 1.5 billion (by 2030) financial opportunity within the peptides and macrocycles drug discovery service and platform providers market has been analyzed across the following segments:
§ Type of peptides
§ Synthetic peptides
§ Biologic and recombinant peptides
§ Type of discovery steps
§ Target identification and validation
§ Hit identification
§ Lead generation
§ Lead optimization
§ Therapeutic Area
§ Oncological disorders
§ Metabolic disorders
§ Cardiovascular disorders
§ Infectious diseases
§ Urological disorders
§ Endocrine disorders
§ CNS disorders
§ Other diseases
§ Company Size
§ Small companies
§ Mid-sized companies
§ Large and very large companies
§ Key geographical regions
- Europe
- North America
- Asia-Pacific and the Rest of the World
The report features inputs from eminent industry stakeholders, according to whom peptide and macrocycles drug discovery outsourcing market is continuously pacing up. The report includes detailed transcripts of discussions held with the following experts:
§ Mark I Peterson (CEO, Cyclenium Pharma)
§ Jan Hoflack (Chief Scientific Officer, Head of Biotech Business Unit, Oncodesign)
The research covers profiles of key players that offer peptides and macrocyclic drugs discovery platforms and services, featuring an overview of the company, its service portfolio / technology platform, and an informed future outlook.
§ GenScript
§ JPT Peptide Technologies
§ CPC Scientific
§ IRBM
§ Creative Peptides
§ Pepscan
§ Interprotein
§ RA Pharmaceuticals
§ Pepticom
§ PeptiDream
§ Creative Biolabs
§ MeSCue-Janusys
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape of Service Providers
5. Benchmark Analysis
6. Market Landscape of Platform Providers
7. Company Profiles
8. Partnerships
9. Market Forecast and Opportunity Analysis
10. SWOT Analysis
11. Conclusion
12. Executive Insights
13. Appendix 1: List of Companies and Organizations
14. Appendix 1: Tabulated Data
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html
Contact Information
Roots Analysis Private Limited
Ben Johnson
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
Medium - https://medium.com/@RootsAnalysis
Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/
